{"transactions":[{"id":719442,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":33290,"kind":"person","name":"Tosca Melissa","position":1,"cik":"0001947184","reported_name":"Tosca Melissa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2026-07-02T20:47:12.000Z","date":"2026-07-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":911,"price":2.66,"value":2423.26,"ownership":{"direct":true},"balance_after":26064,"source":{"system":"sec-edgar","filing":"0001372514-26-000067","document":"wk-form4_1783025229.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1947184/000137251426000067/wk-form4_1783025229.xml","form_type":"4"}},{"id":821164,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":33290,"kind":"person","name":"Tosca Melissa","position":1,"cik":"0001947184","reported_name":"Tosca Melissa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2026-04-02T20:47:03.000Z","date":"2026-04-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":929,"price":1.95,"value":1811.55,"ownership":{"direct":true},"balance_after":26975,"source":{"system":"sec-edgar","filing":"0001372514-26-000034","document":"wk-form4_1775162820.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1947184/000137251426000034/wk-form4_1775162820.xml","form_type":"4"}},{"id":851985,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":33290,"kind":"person","name":"Tosca Melissa","position":1,"cik":"0001947184","reported_name":"Tosca Melissa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Option (right to buy)","published_at":"2026-03-10T20:36:21.000Z","date":"2026-03-06","kind":"grant","planned":false,"acquired":true,"shares":13067,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person received an option to purchase Common Stock from the Issuer pursuant to the Plan. The option will become exercisable as to one-third (1/3) of the shares underlying the Option on April 1, 2027, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":13067,"derivative":{"exercise_price":1.98,"exercise_date":"2027-04-01","expiration_date":"2036-04-01","underlying":"Common Stock","underlying_shares":13067},"source":{"system":"sec-edgar","filing":"0001372514-26-000012","document":"wk-form4_1773174978.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1947184/000137251426000012/wk-form4_1773174978.xml","form_type":"4"}},{"id":851984,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":33290,"kind":"person","name":"Tosca Melissa","position":1,"cik":"0001947184","reported_name":"Tosca Melissa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2026-03-10T20:36:21.000Z","date":"2026-03-06","kind":"grant","planned":false,"acquired":true,"shares":6533,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock from the Issuer pursuant to the Issuer's 2024 Equity Incentive Plan (the \"Plan\"). The restrictions will vest as to one-third (1/3) of the shares on each of April 1 , 2027, April 1 , 2028 and April 1 , 2029, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":27904,"source":{"system":"sec-edgar","filing":"0001372514-26-000012","document":"wk-form4_1773174978.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1947184/000137251426000012/wk-form4_1773174978.xml","form_type":"4"}},{"id":1184742,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":33290,"kind":"person","name":"Tosca Melissa","position":1,"cik":"0001947184","reported_name":"Tosca Melissa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Option (right to buy)","published_at":"2025-04-03T00:29:26.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":15543,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person received an option to purchase Common Stock from the Issuer pursuant to the Plan. The option will become exercisable as to one-third (1/3) of the shares underlying the Option on April 1, 2026, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":15543,"derivative":{"exercise_price":2.93,"exercise_date":"2026-04-01","expiration_date":"2035-04-01","underlying":"Common Stock","underlying_shares":15543},"source":{"system":"sec-edgar","filing":"0001372514-25-000036","document":"wk-form4_1743640160.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1947184/000137251425000036/wk-form4_1743640160.xml","form_type":"4"}},{"id":1184741,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":33290,"kind":"person","name":"Tosca Melissa","position":1,"cik":"0001947184","reported_name":"Tosca Melissa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2025-04-03T00:29:26.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":7772,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock from the Issuer pursuant to the Issuer's 2024 Equity Incentive Plan (the \"Plan\"). The restrictions will vest as to one-third (1/3) of the shares on each of April 1, 2026, April 1, 2027 and April 1, 2028, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":21371,"source":{"system":"sec-edgar","filing":"0001372514-25-000036","document":"wk-form4_1743640160.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1947184/000137251425000036/wk-form4_1743640160.xml","form_type":"4"}},{"id":1432918,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":33290,"kind":"person","name":"Tosca Melissa","position":1,"cik":"0001947184","reported_name":"Tosca Melissa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2024-08-15T20:17:41.000Z","date":"2024-08-14","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":3.21,"value":6420.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were purchased in multiple transactions at prices ranging from $3.16 to $3.26. The reported price of $3.21 represents the volume weighted average price for the reported transaction. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":13599,"source":{"system":"sec-edgar","filing":"0001372514-24-000107","document":"wk-form4_1723753055.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1947184/000137251424000107/wk-form4_1723753055.xml","form_type":"4"}},{"id":1460952,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":33290,"kind":"person","name":"Tosca Melissa","position":1,"cik":"0001947184","reported_name":"Tosca Melissa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Option (right to buy)","published_at":"2024-07-03T19:16:41.000Z","date":"2024-07-01","kind":"grant","planned":false,"acquired":true,"shares":15239,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person received an option to purchase Common Stock from the Issuer pursuant to the Plan. The option will become exercisable as to one-third (1/3) of the shares underlying the Option on July 1, 2025, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":15239,"derivative":{"exercise_price":4.35,"exercise_date":"2025-07-01","expiration_date":"2034-07-01","underlying":"Common Stock","underlying_shares":15239},"source":{"system":"sec-edgar","filing":"0001372514-24-000096","document":"wk-form4_1720034195.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1947184/000137251424000096/wk-form4_1720034195.xml","form_type":"4"}},{"id":1460951,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":33290,"kind":"person","name":"Tosca Melissa","position":1,"cik":"0001947184","reported_name":"Tosca Melissa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2024-07-03T19:16:41.000Z","date":"2024-07-01","kind":"grant","planned":false,"acquired":true,"shares":7620,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock from the Issuer pursuant to the Issuer's 2024 Equity Incentive Plan (the \"Plan\"). The restrictions will vest as to one-third (1/3) of the shares on each of July 1, 2025, July 1, 2026 and July 1, 2027, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":11599,"source":{"system":"sec-edgar","filing":"0001372514-24-000096","document":"wk-form4_1720034195.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1947184/000137251424000096/wk-form4_1720034195.xml","form_type":"4"}},{"id":1479738,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":33290,"kind":"person","name":"Tosca Melissa","position":1,"cik":"0001947184","reported_name":"Tosca Melissa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Finance"}}],"security":"Common Stock","published_at":"2024-06-14T20:47:33.000Z","date":"2024-06-14","kind":"purchase","planned":false,"acquired":true,"shares":100,"price":5.25,"value":525.0,"ownership":{"direct":true},"balance_after":3979,"source":{"system":"sec-edgar","filing":"0001372514-24-000065","document":"wk-form4_1718398034.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1947184/000137251424000065/wk-form4_1718398034.xml","form_type":"4"}},{"id":1768797,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":33290,"kind":"person","name":"Tosca Melissa","position":1,"cik":"0001947184","reported_name":"Tosca Melissa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Finance"}}],"security":"Stock Option (right to buy)","published_at":"2023-10-03T20:49:14.000Z","date":"2023-09-29","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person received an option to purchase Common Stock from the Issuer pursuant to the Plan. The option will become exercisable as to twenty-five percent (25%) of the shares underlying the Option upon grant on September 29, 2023, twenty-five percent (25%) on September 29, 2024 and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":60000,"derivative":{"exercise_price":0.5677,"exercise_date":"2023-09-29","expiration_date":"2033-09-29","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001372514-23-000150","document":"wk-form4_1696366139.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1947184/000137251423000150/wk-form4_1696366139.xml","form_type":"4"}},{"id":1768796,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":33290,"kind":"person","name":"Tosca Melissa","position":1,"cik":"0001947184","reported_name":"Tosca Melissa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Finance"}}],"security":"Common Stock","published_at":"2023-10-03T20:49:14.000Z","date":"2023-09-29","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan (the \"Plan\"). The restrictions will vest as to twenty-five percent (25%) of the shares immediately upon grant, and twenty-five percent (25%) on each of September 29, 2024, September 29, 2025 and September 29, 2026, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":34900,"source":{"system":"sec-edgar","filing":"0001372514-23-000150","document":"wk-form4_1696366139.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1947184/000137251423000150/wk-form4_1696366139.xml","form_type":"4"}},{"id":1967036,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":33290,"kind":"person","name":"Tosca Melissa","position":1,"cik":"0001947184","reported_name":"Tosca Melissa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Finance"}}],"security":"Stock Option (right to buy)","published_at":"2023-03-08T01:15:21.000Z","date":"2023-03-03","kind":"grant","acquired":true,"shares":1600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person received an option to purchase Common Stock from the Issuer pursuant to the Plan. The option will become exercisable as to one-third (1/3) of the shares underlying the Option on March 3, 2024, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":1600,"derivative":{"exercise_price":3.83,"expiration_date":"2033-03-03","underlying":"Common Stock","underlying_shares":1600},"source":{"system":"sec-edgar","filing":"0001372514-23-000036","document":"wf-form4_167823810655536.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1947184/000137251423000036/wf-form4_167823810655536.xml","form_type":"4"}},{"id":1967035,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":33290,"kind":"person","name":"Tosca Melissa","position":1,"cik":"0001947184","reported_name":"Tosca Melissa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Finance"}}],"security":"Common Stock","published_at":"2023-03-08T01:15:21.000Z","date":"2023-03-03","kind":"grant","acquired":true,"shares":2400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan (the \"Plan\"). The restrictions will vest as to one-third (1/3) of the shares on each of March 3, 2024, March 3, 2025 and March 3, 2026, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":7400,"source":{"system":"sec-edgar","filing":"0001372514-23-000036","document":"wf-form4_167823810655536.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1947184/000137251423000036/wf-form4_167823810655536.xml","form_type":"4"}},{"id":2132518,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":33290,"kind":"person","name":"Tosca Melissa","position":1,"cik":"0001947184","reported_name":"Tosca Melissa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP of Finance"}}],"security":"Stock Option (right to buy)","published_at":"2022-10-25T21:32:33.000Z","date":"2022-10-21","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person received an option to purchase Common Stock from the Issuer pursuant to the Plan. The option will become exercisable as to one-third (1/3) of the shares underlying the Option on September 13, 2023, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":5000,"derivative":{"exercise_price":6.78,"expiration_date":"2032-10-21","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001104659-22-111243","document":"tm2228925-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1947184/000110465922111243/tm2228925-2_4seq1.xml","form_type":"4"}},{"id":2132517,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":33290,"kind":"person","name":"Tosca Melissa","position":1,"cik":"0001947184","reported_name":"Tosca Melissa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP of Finance"}}],"security":"Common Stock","published_at":"2022-10-25T21:32:33.000Z","date":"2022-10-21","kind":"grant","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan (the \"Plan\"). The restrictions will vest as to one-third (1/3) of the shares on each of September 13, 2023, September 13, 2024 and September 13, 2025, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":2500,"source":{"system":"sec-edgar","filing":"0001104659-22-111243","document":"tm2228925-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1947184/000110465922111243/tm2228925-2_4seq1.xml","form_type":"4"}}]}